Hepatitis B reduced
Submitted by staff on Fri, 2006-07-28 05:36.
Author(s): Prof. Charles Yeh (papers) Content type: Research Groups: BioMagnetics, Case reports
Six years ago, Mr Lin, the Vice-President of an Air Cargo company, developed complications due to Hepatitis B infection. He had a Hepatitis B surface antigen (HBsAg) index that was three orders of magnitude greater than normal.
At the National Taiwan University Hospital, he was prescribed with interferon-alpha therapy under the guidance of Dr. Lai. Although he showed a positive response to the therapy in the beginning, the improvement did not continue for long. Frustrated, Mr. Lin started to try the enhanced ‘Tsi-Bao” approach along with the therapy.
The result of the next routine check 4 months later, was amazing -- the index came down from three to only two orders of magnitude, a ten-fold reduction. Dr. Lai was amazed with the improvement. (Tsi-Bao is Daytime Therapy over sternum.)
At the National Taiwan University Hospital, he was prescribed with interferon-alpha therapy under the guidance of Dr. Lai. Although he showed a positive response to the therapy in the beginning, the improvement did not continue for long. Frustrated, Mr. Lin started to try the enhanced ‘Tsi-Bao” approach along with the therapy.
The result of the next routine check 4 months later, was amazing -- the index came down from three to only two orders of magnitude, a ten-fold reduction. Dr. Lai was amazed with the improvement. (Tsi-Bao is Daytime Therapy over sternum.)
Coordinated by Professor Charles Yeh
